top of page
Search
Cancer Center Associates
Mar 8, 20212 min read
FDA Approves Libtayo for NSCLC With High PD-L1 Expression
Libtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
110 views
Dr. Amanullah Khan MD
Mar 8, 20211 min read
TAGRISSO- New Indications for Non Small Cell Lung Cancer!
New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
129 views
Dr. Farhan Mohammad MD
Sep 23, 20201 min read
Acute promyelocytic leukemia (APL) in a patient with Crohn's disease and exposure to infliximab: a
A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported
165 views
Dr. Farhan Mohammad MD
Sep 23, 20203 min read
Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
Composite lymphoma is an extremely rare clinical entity.
129 views0 comments
Cancer Center Associates
Sep 23, 20201 min read
Patients' Experience with Dr. Khan
U. S. News & World Report When choosing a provider, it can be helpful to review other patients' experiences. U.S. News publishes patient...
131 views0 comments
Dr. Farhan Mohammad MD
Sep 23, 20202 min read
Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens
Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer.
58 views
Dr. Amanullah Khan MD
Apr 18, 20201 min read
New drug approval by FDA for MDS related anemia
On April 3, 2020, the Food and Drug Administration approved new treatment for MDS related anemia.
175 views0 comments
Cancer Center Associates
Apr 7, 20201 min read
Our Response to COVID-19
We are making a few changes to our standard process. Here are the instructions for coming to the office during the COVID-19 pandemic.
75 views0 comments
bottom of page